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Abstract: The relationship between dietary intake, circulating hepcidin and iron status in free-living
premenopausal women has not been explored. This cross-sectional study aimed to identify dietary
determinants of iron stores after accounting for blood loss and to determine whether iron intake
predicts iron stores independently of hepcidin in a sample of Australian women. Three hundred thirty
eight women aged 18–50 years were recruited. Total intake and food sources of iron were determined
via food frequency questionnaire; the magnitude of menstrual losses was estimated by self-report;
and blood donation volume was quantified using blood donation records and self-reported donation
frequency. Serum samples were analysed for ferritin, hepcidin and C-reactive protein concentrations.
Linear regression was used to investigate associations. Accounting for blood loss, each 1 mg/day
increase in dietary iron was associated with a 3% increase in iron stores (p = 0.027); this association was
not independent of hepcidin. Hepcidin was a more influential determinant of iron stores than blood
loss and dietary factors combined (R2 of model including hepcidin = 0.65; R2 of model excluding
hepcidin = 0.17, p for difference <0.001), and increased hepcidin diminished the positive association
between iron intake and iron stores. Despite not being the biggest contributor to dietary iron intake,
unprocessed meat was positively associated with iron stores, and each 10% increase in consumption
was associated with a 1% increase in iron stores (p = 0.006). No other dietary factors were associated
with iron stores. Interventions that reduce hepcidin production combined with dietary strategies
to increase iron intake may be important means of improving iron status in women with depleted
iron stores.
Keywords: iron status; female; blood donation; menstrual loss; iron intake; hepcidin
1. Introduction
Iron deficiency is the most prevalent nutritional disorder worldwide [1]. It has been estimated
that in Australia, 12% of women aged between 16–44 years present with depleted iron stores
(serum ferritin < 15 µg/L [2]) and are thus more likely to experience impaired physical performance [3]
and potentially impaired cognitive ability [4–6]. Iron homeostasis is maintained via intestinal
absorption, with iron absorption increasing when iron status is impaired [7,8]. Absorption is
determined in part by hepcidin, a peptide hormone produced by the liver in response to conditions
including iron concentration [9]. Hepcidin regulates the export of iron into circulation by binding
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to the iron transport protein, ferroportin, thereby trapping iron in enterocytes and macrophages [9].
When the iron concentration of the body is low, hepcidin production is suppressed, and iron absorption
and cycling increase [9].
Dietary influences of iron absorption include the form of iron and simultaneous consumption of
other food components. Heme iron is more bioavailable than non-heme iron [10], and the bioavailability
of iron in a whole diet is increased by the consumption of ascorbic acid and meat protein [11]. In single
meals, iron absorption is reduced by consumption of phytate [12,13] and potentially calcium [13,14],
as well as polyphenols in tea and coffee [15,16], although data from free-living populations are
lacking. Iron intake has a positive influence on iron status, with each 1 g/day increase of elemental iron
associated with a 1 µg/L increase in serum ferritin [17]. However, there exists inter-individual variation
in iron absorption that may be caused by genetic variation in hepcidin expression [18–20]. It has been
postulated that this variation in expression may be a greater influence of iron absorption than dietary
factors [21], but there is no evidence exploring the relationships between dietary intake, hepcidin
concentration and iron status in free-living individuals. In a single-meal study, Zimmermann et al. [20]
found that circulating hepcidin explained a ”modest” 28% of variance in absorption, leading the
authors to suggest that additional physiological and genetic factors are important in influencing
absorption [20].
As iron concentration of the body influences hepcidin expression, blood loss, as a major source
of iron loss and, thus, a determinant of iron concentration, should be considered when investigating
determinants of iron stores. The progressively deleterious effect of regular blood donation on iron
stores has been recognized since the late 1970s [22], and greater menstrual losses increase women’s
risk of iron deficiency [23]. Erythropoietic activity leads to a reduction in hepcidin expression [9],
and hepcidin concentrations decline with repeated blood donations, although there is a great deal of
variance in this response [24]. Furthermore, in inflammatory states, ferritin and hepcidin concentrations
are both elevated, and if prolonged, iron absorption can be suppressed, resulting in anaemia of
inflammation [25]. Pro-inflammatory conditions may impair iron status, and there is evidence of higher
circulating hepcidin concentrations and impaired iron status in women with obesity [26,27]. There is
therefore a need to account for inflammation when investigating ferritin and hepcidin. As hepcidin
measurement is relatively novel, there are no published studies considering the combined effect of
blood loss, iron intake and hepcidin on iron status. Studies investigating predictors of iron stores
in premenopausal women, including blood donation, menstrual losses or oral contraceptive use,
and intakes of iron or iron-rich foods have only predicted 9% of variance in serum ferritin [28,29].
These data indicate that other factors must play a significant role in determining iron status, and one
of these factors may be hepcidin. The aims of this study were to identify dietary determinants of
iron stores after accounting for blood loss and to determine whether iron intake predicts iron stores
independently of circulating hepcidin levels in a sample of premenopausal women.
2. Materials and Methods
2.1. Study Design and Participants
Premenopausal women 18–50 years of age were recruited for this cross-sectional study as
described elsewhere [30]. Briefly, 396 women were recruited from the student and staff population at
Deakin University (Burwood, Melbourne, Australia), from blood donors registered with the Australian
Red Cross Blood Service (Blood Service, Sydney, Australia) and from metropolitan Melbourne from
July 2010–January 2014. All participants provided written informed consent at the time of recruitment.
Ethics approval for data collection between 2010 and 2011 was granted by the Deakin University
Human Research Ethics Committee (Reference 2009-191) and by the Australian Red Cross Blood
Service Ethics Committee (Reference 2010#01). Ethics approval for data collection between 2012 and
2014 was granted by the Deakin University Human Research Ethics Committee (Reference 2012-046).
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Women were eligible to participate if they had not been through menopause and if they were
not currently pregnant or lactating and had not been in the previous 6 months. The presence of
chronic disease was not an exclusion criterion. Participants were asked to complete a demographic
and health background questionnaire, a food frequency questionnaire (FFQ) and to provide a blood
sample. Of the 382 women who completed both questionnaires, 342 also provided a blood sample.
Data from four women were excluded from analyses: three women reported energy intakes > 3 SD
from the mean (>14,846 kJ/day), and one woman had recently received an intravenous iron infusion
(serum ferritin = 461 µg/L). In total, 338 women were included in the present study, 313 in the analysis
of dietary determinants of iron stores and 265 in the analysis of hepcidin as a determinant of iron stores
(Figure 1).
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2.2. Assessment of Usual Dietary Intake
Women’s usual dietary intakes over the past 12 months were recorded using the Cancer Council
Victoria Dietary Questionnaire for Epidemiological Studies v3.1 (DQES v3.1), a paper-based FFQ that
assesses the consumption frequency of 140 foods and beverages and can be used to estimate nutrient
intakes [31]. Dietary iron intake reported in the previous version of this FFQ [31] has been validated
against seven-day weighed food records [32]. As explained previously [30], nutritional analysis of
DQES v3.1 was conducted independently of the Cancer Council Victoria. Usual nutrient intakes
per day, including mg/day dietary iron and ascorbic acid, were calculated using Australian food
composition databases NUTTAB 2010 [33] and AUSNUT 2007 [34] via FoodWorks 7 (Xyris Software,
Queensland, Australia) [30]. As the Australian food composition databases do not include phytate,
daily phytate intake was estimated separately using the University of Otago’s (Dunedin, New Zealand)
database of the phytate content of 5775 foods and beverages [35]. This database was based on published
literature of phytate concentration in foods, which were adjusted to reflect food processing methods in
New Zealand [35], and was considered by the authors as the most appropriate for an Australian
population. Phytate intakes were computed using Microsoft Excel 2013 (Microsoft Corporation,
Redmond, WA, USA).
Food group contributions to dietary iron intakes were estimated following the food grouping
system used in the 2011 Australian Health Survey (AHS 2011) [36]. As with AHS 2011 [37],
these contributions were estimated at the group level: the mean mg/day contributed by each AHS
2011 major and sub-major food group was divided by the mean mg/day dietary iron intake of the
cohort and multiplied by 100 to present as a percentage.
2.3. Assessment of Supplemental Iron Intake
Use of dietary supplements containing iron was self-reported. Women were asked to write
the name of any supplements they were currently using that contained iron, the frequency of
consumption and the dose. The dose of supplemental iron (as elemental iron) was confirmed by
checking supplement packaging or the manufacturers’ websites. To estimate supplemental iron intake
per day, the total amount of iron from all supplements consumed per week was divided by seven days.
Supplemental iron intakes were added to dietary intakes to determine total iron intakes per day.
2.4. Assessment of Blood Loss
The sources of blood loss included in this study were blood donation, menstrual losses
and nosebleeds.
The blood donation history of women recruited at the Blood Service was sourced from Blood
Service records. The information consisted of the number of donations made over the past 12 months
and the donation type at each visit (whole blood or apheresis). The volume of blood donated over
the past year was quantified using conversion factors provided by the Blood Service. Each whole
blood donation was considered to be 470 mL, and each apheresis (plasmapheresis and plateletpheresis)
donation was considered to be 60 mL of whole blood.
Women recruited at Deakin University in 2010 self-reported their blood donor status and
frequency of donation. This information was converted to mL of blood donated over the past year
using the factors noted above. Women recruited at Deakin University in 2012–2014 had not donated
blood in the past two years as an eligibility criterion.
A previously-published questionnaire was used to record self-reported menstrual blood loss [38].
Women were asked to report menstrual characteristics, including frequency of menses per year;
the number of heavy and light days during menses; and the number, type and brand of sanitary
pads and tampons used on heavy and light days. This information was used to calculate an arbitrary
menstrual blood loss score for each woman per menses and per year. This questionnaire assessing
menstrual blood loss per menses has been validated among women aged 18–29 years in New Zealand
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where the arbitrary menstrual blood loss score was positively and moderately correlated with the
weight of women’s menstrual products [38].
Experience of nose bleeds was recorded using a categorical question (i.e., “Do you get nose
bleeds?” (Yes/No)).
2.5. Biochemical Analyses
Participants were asked to provide blood samples that were analysed for serum ferritin,
haemoglobin, C-reactive protein (CRP) and hepcidin concentrations. Women recruited in Melbourne
were asked to provide a fasting intravenous blood sample that was collected and analysed for serum
ferritin, haemoglobin and CRP by Dorevitch Pathology (Heidelberg, Victoria, Australia), a commercial
pathology laboratory. Serum ferritin was measured using the ADVIA Centaur Ferritin Assay on the
Siemens ADVIA Centaur (Siemens Healthcare Diagnostics, Deerfield, IL, USA), haemoglobin measured
using the Sysmex Automated Hematology Analyzer XE-2100 (Sysmex, Kobe, Japan) and CRP measured
using a latex-enhanced immunoturbidimetric assay on a Siemens ADVIA 2400 (Bayer Diagnostics,
Tarrytown, NY, USA). Women recruited at the Blood Service provided non-fasting blood samples
as sampling occurred just prior to a blood donation, and the Blood Service performed analysis of
serum ferritin, haemoglobin and CRP. At the Blood Service, intravenous samples were used for serum
ferritin and CRP analyses and capillary finger-stick samples for haemoglobin analysis. Serum ferritin
was measured using the AxSYM Ferritin assay on the AxSYM (Abbott Diagnostics, Abbott Park,
IL, USA); haemoglobin was measured using the Hemocue B-Hemoglobin Photometer (Hemocue,
Angelholm, Sweden); and CRP was measured using the Quantikine Human CRP Immunoassay
(R & D Systems, Minneapolis, MN, USA). The time of blood sampling was recorded by staff at
Dorevitch Pathology and the Blood Service. Blood sampling took place between 7:40 and 18:30
and 8:00 and 16:55 for the Melbourne and Sydney cohorts, respectively. Both Dorevitch Pathology and
the Blood Service are accredited with the National Association of Testing Authorities (Australia) in
conjunction with the Royal College of Pathologists of Australasia and comply with the requirements
of ISO 15189:2012. For all participants, at the time of sampling, an aliquot of serum was stored at
−70 ◦C at Deakin University (Burwood, Victoria, Australia) for hepcidin analysis. Serum hepcidin
was analysed at Deakin University using a competitive enzyme immunoassay kit for hepcidin-25
(catalogue number S-1337, Bachem/Peninsula Laboratories, San Carlos, CA, USA).
2.6. Assessment of Covariates
The demographic and health background questionnaire given to participants collected information
including country of birth, highest education, employment status, smoking status and use of oral
contraception. All participants had weight measured. Women from Melbourne had height measured
using a wall-mounted stadiometer, while women from Sydney self-reported height as part of
the background questionnaire. Body mass index (BMI) was calculated as weight (kg) divided by
height (m2).
2.7. Statistical Analysis
All statistical tests were two-sided, and statistical significance was defined as p < 0.05. Analyses
were conducted using Stata/SE 13.1 (StataCorp, College Station, TX, USA). Descriptive statistics are
presented as n (%) or the mean (95% CI). The normality of variables was assessed through visual
inspection of histograms, and data were natural log-transformed and presented as the geometric mean
(95% CI) if the distribution was not normal. Normality was confirmed after log transformation.
For descriptive statistics, serum ferritin concentrations were multiplied by a factor of 0.65 if
CRP > 5 mg/L (n = 34) to correct serum ferritin concentrations for inflammation [39]. Inferential statistics
used uncorrected serum ferritin values with CRP included as a covariate in models. As hepcidin
concentrations are also elevated in an inflammatory state [25], inclusion of CRP in inferential analyses
was required. Women were categorized as having low iron stores if inflammation-corrected serum
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ferritin values < 15 µg/L and haemoglobin values≥ 120 g/L and categorized as having iron-deficiency
anaemia if serum ferritin values < 15 µg/L and haemoglobin values < 120 g/L [40].
The inferential analysis was performed in three steps. Firstly, blood loss, demographic and
anthropometric characteristics outlined in Section 2.6 were selected in a linear regression model
predicting serum ferritin using automated backwards selection with the criterion of p ≤ 0.2 [41].
Dietary characteristics selected a priori were then added to the model to test: (a) intakes of the major
food sources of iron and an absorption inhibitor (phytate) and enhancer (ascorbic acid); (b) dietary
intakes of iron, phytate and ascorbic acid; and (c) total intakes of iron (dietary + supplemental iron)
and dietary intakes of phytate and ascorbic acid. To explore whether an inhibitory effect of phytate on
an association between iron intake and iron stores is dependent on ascorbic acid intake, we included
an interaction between mg/day intakes of phytate, iron and ascorbic acid. Secondly, we included
hepcidin concentration in multivariate models of serum ferritin that included dietary or total iron
intake. To further investigate the impact of hepcidin, we included an interaction between iron intake
(mg/day) and serum hepcidin (ng/mL) on serum ferritin concentrations, and this interaction was
visualized using the post-estimation “margins” command. The time of blood sampling was included
as a covariate in models with hepcidin to account for diurnal variation [42]. Natural log-transformation
of serum ferritin, CRP, hepcidin, meat consumption and phytate intake was used to correct skewness
that violated assumptions of regression residuals. The presence of collinearity among independent
variables was determined using the criterion of r ≥ 0.8 [41], with Pearson’s correlation used for
normally-distributed variables and Spearman’s correlation used for skewed variables.
3. Results
Women in this study were aged on average 29 (95% CI 28, 30) years, and most were in the healthy
weight range (Table 1). In the study sample, the prevalence of low iron stores (using serum ferritin
values corrected for inflammation in 34 women) in the absence of anaemia was 30% (n = 100), and an
additional 7% (n = 22) presented with iron-deficiency anaemia.
Table 1. Characteristics of the study sample of premenopausal women aged 18–50 years a.
Total (n = 338)
Demography and anthropometry
Age (years) 29.1 (28.3, 29.9)
Body mass index (kg/m2) 24.0 (23.6, 24.4)
Underweight b 11 (3%)
Normal weight b 224 (67%)
Overweight b 69 (21%)
Obese b 29 (9%)
Tertiary education 274 (81%)
Currently employed 297 (89%)
Current smoker 26 (7%)
Has children 55 (16%)
Diet and supplements
Dietary iron intake (mg/day) 10.4 (10.0, 10.8)
Taking supplements containing iron 71 (21%)
Supplemental iron intake among users (mg/day, n = 71) c 7.2 (5.3, 9.8)
Total iron intake (diet + supplements) c 11.4 (10.7, 12.0)
Dietary ascorbic acid intake (mg/day) 121 (115, 127)
Phytate intake (mg/day) 691 (653, 733)
Energy intake (MJ/day) 7.7 (7.4, 7.9)
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Table 1. Cont.
Total (n = 338)
Blood loss
Donated blood in previous 12 months 159 (47%)
Amount donated (mL/year, n = 159) 844 (769, 919)
Using oral contraception 125 (37%)
Menstrual blood loss units per menses c 30 (28, 33)
Menstrual blood loss units per year c 82 (76, 89)
Experiences nosebleeds 36 (11%)
Biochemistry
Serum ferritin (µg/L) a,d 19.1 (17.3, 21.0)
Venous haemoglobin (g/L, n = 147) 135 (133, 136)
Capillary haemoglobin (g/L, n = 191) 130 (129, 132)
Hepcidin (ng/mL) c 5.84 (5.01, 6.79)
a Values are the arithmetic mean (95% CI) unless indicated as the geometric mean (95% CI) or n (%).
Characteristics of the 265 women with hepcidin data are nearly identical and, thus, not presented separately.
b Categories of body mass index: underweight <18.50 kg/m2; normal range 18.50–24.99 kg/m2; overweight
25.00–29.99 kg/m2; obese >30.00 kg/m2 [43]. c Values are the geometric mean (95% CI). d Serum ferritin
corrected for acute infection: in women with CRP ≥ 5 mg/L (n = 34), serum ferritin was multiplied by a factor
of 0.65, as suggested by Thurnham et al. [39].
One-third of dietary iron consumed by the study sample was sourced from cereals and cereal
products (including breakfast cereals and breads); 16% was sourced from vegetable products and
dishes; and 14% was sourced from meat and poultry (Table 2).
Table 2. Contribution of foods to dietary iron intake among the study group of women aged
18–50 years a,b.
Food Group Contribution to Dietary IronIntake (% (95% CI))
Cereals and cereal products 30.1 (28.8, 31.5)
Breakfast cereals, ready to eat 11.9 (10.5, 13.3)
Regular breads and bread rolls (plain/unfilled/untopped varieties) 10.8 (10.1, 11.6)
Flours and other cereal grains and starches 3.7 (3.2, 4.1)
Breakfast cereals, hot porridge style 2.1(1.7, 2.5)
Pasta and pasta products (without sauce) 1.6 (1.5, 1.7)
Cereal based products and dishes 6.1 (5.7, 6.5)
Savoury biscuits 2.0 (1.7, 2.2)
Cakes, muffins, scones, cake-type desserts 1.4 (1.3, 1.6)
Pastries 1.1 (1.0, 1.3)
Vegetable products and dishes 16.1 (15.2, 16.9)
Leaf and stalk vegetables 6.2 (5.7, 6.7)
Other fruiting vegetables 2.5 (2.4, 2.7)
Cabbage, cauliflower and similar brassica vegetables 2.3 (2.1, 2.6)
Peas and beans 1.8 (1.6, 2.0)
Tomato and tomato products 1.0 (1.0, 1.1)
Carrot and similar root vegetables 1.0 (0.9, 1.1)
Meat, poultry and game products and dishes 13.9 (12.8, 15)
Beef, sheep and pork, unprocessed 8.7 (7.9, 9.5)
Poultry and feathered game 2.7 (2.4, 2.9)
Processed meat 1.9 (1.6, 2.2)
Fruit products and dishes 8.8 (8.3, 9.3)
Tropical and subtropical fruit 1.9 (1.7, 2.0)
Berry fruit 1.9 (1.7, 2.0)
Other fruit 1.8 (1.7, 2.0)
Stone fruit 1.2 (1.0, 1.3)
Nutrients 2016, 8, 540 8 of 15
Table 2. Cont.
Food Group Contribution to Dietary IronIntake (% (95% CI))
Legume and pulse products and dishes 3.4 (2.9, 3.9)
Seed and nut products and dishes 3.2 (2.9, 3.6)
Non-alcoholic beverages 3.2 (3.0, 3.5)
Confectionery and cereal/nut/fruit/seed bars 2.6 (2.3, 2.9)
Chocolate and chocolate-based confectionary 2.5 (2.2, 2.7)
Milk products and dishes 2.2 (2.0, 2.3)
Miscellaneous 2.1 (1.8, 2.4)
Egg products and dishes 1.9 (1.7, 2.1)
Fish and seafood products and dishes 1.7 (1.5, 1.9)
Dairy and meat substitutes 1.6 (1.2, 2.0)
Alcoholic beverages 1.3 (1.1, 1.5)
Savoury sauces and condiments 1.0 (0.9, 1.2)
a Major and sub-major groups as defined in the 2011 Australian Health Survey [37]. b Major and sub-major
food groups contributing < 1% of dietary iron were omitted from this list. Major groups omitted for this reason
were snack foods, sugar products and dishes and fats and oils.
3.1. Predictors of Iron Stores
Of the blood loss, demographic and anthropometric characteristics, only blood losses through
blood donation and menstruation met the criterion for selection into the model. Although BMI
and CRP were moderately and positively correlated (Spearman’s r = 0.35, p < 0.001), BMI was not
selected into the model as a predictor of serum ferritin. Age, BMI, education, employment, status as
a smoker and having had children were not associated with serum ferritin. Including a dichotomous
variable of location (Sydney/Melbourne) did not change the associations between blood loss and
serum ferritin. When the dietary characteristics were added to the model, the multivariate analyses
(Table 3) demonstrated that usual dietary iron intake was a determinant of iron stores, with each
1 mg/day increase in dietary iron associated with a 5% (95% CI 1, 8%) increase in serum ferritin and
each 10% increase in total iron (dietary + supplemental iron) intake associated with a 3% (95% CI 1, 5%)
increase in serum ferritin. Applying this information to the study sample, a 1 mg/day increase in
dietary iron or a 10% increase in total iron intake would see the serum ferritin geometric mean increase
from approximately 20–21 µg/L. Dietary sources of iron were not equally associated with serum
ferritin. Intakes of cereals and cereal products (including breakfast cereals and breads) and vegetable
products and dishes were not associated with iron stores (β for cereals = 0.090, 95% CI −0.080, 0.260;
β for vegetables = 0.001, 95% CI 0, 0.002), despite contributing 30 and 16% of dietary iron intake,
respectively. However, a small positive association was observed between iron stores and total
unprocessed meat consumption (β for total meat = 0.089, 95% CI 0.006, 0.171), which contributed to
14% of dietary iron intakes. Each 10% increase in intakes of combined red and white meat corresponded
to a 0.9% (95% CI 0.6, 1.7%) increase in serum ferritin (e.g., an increase in total meat consumption from
78–86 g/day would equate to serum ferritin increasing from 20.1–20.3 µg/L). Usual dietary intakes of
ascorbic acid and phytate were not associated with iron stores, and a three-way interaction between
intakes of phytate, ascorbic acid and iron was not significant (data not shown). For each 100 mL of
whole blood donated, serum ferritin decreased by 8% (95% CI 6, 10%), and for each arbitrary unit
increase in menstrual loss, serum ferritin decreased by 0.2% (95% CI 0.1, 0.4%).
3.2. Association between Iron Intake and Iron Stores Independent of Hepcidin
Hepcidin data were available for 265 women. When the multivariate analyses were repeated in
only these 265 women, no differences were observed in outcomes compared with the analyses that
included 313 women (data not shown). There was a positive correlation between hepcidin and serum
ferritin, with Spearman’s r = 0.67, p < 0.001. Including natural log-transformed hepcidin concentration
in models increased the amount of explained variance in serum ferritin from 20% (Table 3) to 65%
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(Table 4). The relationship between log-transformed serum ferritin and hepcidin also remained when
repeating the analysis (Table 4, Model A) in only the women who provided fasting morning samples
(β for log-transformed serum hepcidin 0.86 (95% CI 0.72, 1.01)). Furthermore, dietary iron intake was
no longer associated with iron stores when hepcidin was included as a covariate, although the positive
association with total iron intake remained. We also explored interactions between dietary iron intake
or total iron intake and circulating hepcidin in these models. Including an interaction of dietary iron
intake (mg/day) × log-transformed hepcidin was found to be negative and statistically significant
(β-0.030 (95% CI −0.053, −0.007)) and indicated that a positive association between dietary iron intake
and iron stores was strongest when circulating hepcidin concentrations were low. This association
remained when a variable indicating the location of recruitment (Sydney/Melbourne) was added to
the model. Figure 2 displays this interaction at different levels of hepcidin concentration. The change
in the slope of natural log-transformed serum ferritin on dietary iron intakes was predicted across the
sample’s range of natural log-transformed hepcidin values from 0–3.2 (1–24.54 ng/mL) at intervals of
0.4, holding blood loss covariates at their mean. The positive association between dietary iron intake
and log-transformed serum ferritin was strongest at 1 ng/mL hepcidin (i.e., greatest changes in slope),
progressively weakening as the intervals of hepcidin concentrations increased. At 7.39, 11.02, 16.44
and 24.53 ng/mL hepcidin, there was no association between dietary iron intake and iron stores.
Table 3. Multivariate models of determinants of serum ferritin concentration in women aged 18–50
years (n = 313) a,b.
β 95% CI p
Model A: Major food sources of dietary iron
and intakes of dietary ascorbic acid and phytate
Adj. R2 = 0.20, p < 0.001
Blood donation (100 mL/year) −0.077 −0.095, −0.059 <0.001
Arbitrary menstrual blood loss units per year −0.002 −0.004, −0.001 0.001
Red + white meat (g/day) b,c 0.089 0.006, 0.171 0.035
Cereals and cereal products (g/day) b,d,e 0.090 −0.080, 0.260 0.30
Vegetable products and dishes (g/day) d 0.001 0, 0.002 0.07
Ascorbic acid (mg/day) −0.001 −0.003, 0.001 0.29
Phytate (mg/day) a −0.011 −0.193, 0.172 0.91
Model B: Dietary intakes of iron, ascorbic acid
and phytate
Adj. R2 = 0.20, p < 0.001
Blood donation (100 mL/year) −0.075 −0.093, −0.057 <0.001
Arbitrary menstrual blood loss units per year −0.003 −0.004, −0.001 <0.001
Dietary iron intake (mg/day) 0.047 0.011, 0.083 0.011
Ascorbic acid (mg/day) −0.001 −0.003, 0.001 0.23
Phytate (mg/day) b −0.094 −0.303, 0.115 0.38
Model C: Total iron intake and dietary intakes
of ascorbic acid and phytate
Adj. R2 = 0.21, p < 0.001
Blood donation (100 mL/year) −0.076 −0.095, −0.058 <0.001
Arbitrary menstrual blood loss units per year −0.002 −0.004, −0.001 0.001
Total iron intake (incl. Supplements, mg/day) b 0.299 0.091, 0.506 0.005
Ascorbic acid (mg/day) −0.001 −0.003, 0.001 0.30
Phytate (mg/day) b −0.046 −0.232, 0.140 0.63
a All models adjusted for C-reactive protein. b Natural log-transformed independent variable. c Red and white
meat includes unprocessed beef, lamb, pork, chicken and fish. d Australian Health Survey major food group.
e Cereals and cereal products includes breakfast cereals, bread, pasta and rice.
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Table 4. Multivariate associations between dietary iron intake, total iron intake, hepcidin and natural
log-transformed serum ferritin in women aged 18–50 years (n = 265) a.
β 95% CI p
Model A: Dietary iron intake
Adj. R2 = 0.65, p < 0.001
Blood donation (100 mL/year) −0.029 −0.043, −0.015 <0.001
Arbitrary menstrual loss units per year −0.001 −0.002, 0 0.036
Dietary iron intake (mg/day) 0.011 −0.009, 0.031 0.27
Timing of sampling (h) −0.080 −0.113, −0.047 <0.001
Hepcidin (ng/mL) b 0.788 0.704, 0.872 <0.001
Model B: Total iron intake
Adj. R2 = 0.66, p < 0.001
Blood donation (100 mL/year) −0.030 −0.045, −0.016 <0.001
Arbitrary menstrual loss units per year −0.001 −0.002, 0 0.05
Total iron intake (mg/day) b 0.155 0.028, 0.281 0.017
Timing of sampling (h) −0.075 −0.109, −0.042 <0.001
Hepcidin (ng/mL) b 0.784 0.699, 0.868 <0.001
a All models adjusted for natural log-transformed C-reactive protein. b Natural log-transformed independent
variable.
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Figure 2. Effect of serum hepcidin on the relationship between dietary iron intake and natural
log-transformed serum ferritin concentration, holding CRP, blood donation and menstrual losses
at their mean values (CRP 0.67 mg/L, blood donation 400 mL/year, menstrual loss 104 arbitrary units,
blood sampling at 11:15). The association between dietary iron intake and natural log-transformed
serum ferritin is non-significant at 7.39 and 11.02 ng/mL (hepcidin concentrations > 11.02 ng/mL not
depicted).
4. Discussion
Although dietary iron intake was associated with iron stores in this sample of premenopausal
women, intake did not predict iron stores independently of circulating hepcidin concentration.
Circulating hepcidin was notably more influential and explained more variance in iron stores
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than diet and blood loss combined (65% of variance including hepcidin, 20% of variance,
excluding hepcidin). Furthermore, this study demonstrated that increasing concentrations of circulating
hepcidin suppressed the association between usual dietary iron intake and iron stores, indicating the
physiological significance of hepcidin in maintaining iron stores in free-living women. The relationship
between dietary intake and iron stores was strongest at the lowest levels of circulating hepcidin, and as
hepcidin concentration increased, the association between iron stores and intake weakened, such that
there was no relationship when hepcidin was greater than 7.39 ng/mL. This value is presented
tentatively, as it has been noted that absolute hepcidin values differ across measurement methods,
likely due to the hepcidin values manufacturers assign to assay standards [44]. However, these results
are in line with the work demonstrating that the amount of iron absorbed is inversely associated with
circulating hepcidin [18–20] and also demonstrate the influence of hepcidin in the determination of iron
stores. These findings are important, as they demonstrate the necessity for an increased understanding
of determinants of hepcidin and the potential to influence hepcidin concentrations. While genetic
factors have a significant influence on circulating concentrations of hepcidin (for a review see [45]),
identifying determinants that can be modified through lifestyle changes or other interventions may
help prevent or treat iron deficiency related to increased hepcidin production. Recent work has shown
that black soybean extract can inhibit hepcidin production and increase circulating iron in animal
models [46], indicating that hepcidin can be actively modified, and the expression is not only a response
to genetic influences, inflammation or hypoxic states. Interestingly, we did not observe a significant
interaction between total iron intake (i.e., dietary and supplemental iron) and hepcidin in this sample
of women. As only 20% of the sample reported taking supplements containing iron, the study
may have been underpowered to detect any influence of supplements. It is also possible that more
information on women’s supplemental use, such as duration of use, was required. Supplement users
may have included women who had only been taking iron supplements for a short period, before the
supplemental iron may have been reflected in iron stores.
In our sample of women, each 1 mg/day increase in dietary iron intake corresponded to a 5%
increase in serum ferritin. Similar associations were observed when iron from supplements was
included, such that a 10% increase in total iron intake corresponded to a 3% increase in iron stores.
These quantifications of the influence of iron intake on iron stores are unique, as most cross-sectional
work in premenopausal women has not found positive associations between dietary iron intake and
iron status [47]. We also observed that the source of dietary iron appeared to influence iron stores.
Although dietary iron intake was a significant determinant of iron stores, intakes of the two major food
groups contributing to dietary iron intake were not: cereals (contributing 31% of dietary iron) and
vegetables (contributing 16%). In contrast, consumption of meat (beef, lamb, chicken, pork; combined
contribution 14%) was consistently positively associated with iron stores whether considered separately
as red or white meat or combined. This finding adds to the body of existing evidence supporting the
positive effect of meat consumption on iron absorption and iron status [11,29,48–50], which may be
due to the more efficient absorption of heme iron compared to non-heme iron [51]. The relationship
may also represent the overall diet quality of women consuming unprocessed meats, rather than meat
intake itself. For example, Beck et al. used factor analysis to describe dietary patterns among a cohort
of premenopausal women and found that women adhering to a pattern characterized by high intakes
of beef and poultry (distinct from “prepared meats”), as well as broccoli, carrots and capsicum were
41% less likely to present with serum ferritin < 20 µg/L [52]. We did not observe any associations
between consumption of iron absorption enhancers other than meat (e.g., ascorbic acid) or potential
inhibitors (e.g., phytate, calcium, tea and coffee tannins) and iron stores, an unsurprising finding, given
that we did not account for the timing of consumption. Timing of consumption may be an important
influence, and it has been demonstrated that beverage tannins have no effect on iron absorption if
consumed one hour prior to food, but hinder iron absorption if consumed with or one hour following
food [16]. Therefore, further research that can account for women’s habitual meal patterns is required.
Nutrients 2016, 8, 540 12 of 15
Although there was a positive, moderate correlation between CRP and BMI, there was no
association between serum ferritin and BMI in our sample of women. Previous studies have reported
inverse relationships between iron status and BMI [27], and the lack of a relationship in the current
study may be due to the small proportion of participants with BMI in the obese range (9%).
Further, lower iron status has been observed in women with obesity compared to women of normal
weight [26], but mean BMI in these obese women (50 kg/m2) was much higher than in the present
study. As the prevalence of obesity in Australia has steadily increased over time [53], there is a need
for work that can ascertain whether and at what stage excess adiposity impairs iron status.
The outcomes from our study need to be considered in light of the following limitations.
First, our study sample of women was a self-selected group that was not representative of premenopausal
women in Australia. Women who participated in this study were more likely to fall in the healthy
weight range [54], less likely to smoke [54] and more likely to be tertiary educated [55] compared to
the general population. While a lack of representativeness limits confident extrapolation of prevalence
data and point estimates, we were still able to identify factors associated with impaired iron stores
and an effect of hepcidin in line with current understanding. Although, as with all cross-sectional
studies, causal pathways could not be determined in this research, directionality could be inferred
from the assessed determinants. For example, negative associations between blood loss and iron
stores implied increased blood loss reduced iron stores, rather than reduced iron stores increasing
blood loss. Nonetheless, stronger study designs are needed to substantiate the dietary determinants
assessed in this research. We also acknowledge that immunoassays for hepcidin-25 can demonstrate
cross-reactivity with hepcidin-20 and hepcidin-22 [56], isoforms that do not affect iron metabolism,
and research with more specific measurement of hepcidin-25 is needed.
5. Conclusions
In conclusion, we observed circulating hepcidin to be a major determinant of iron stores,
and increased levels of hepcidin suppressed the association between dietary iron intake and iron
stores in free-living premenopausal women. We also found meat consumption to be a positive
determinant of iron stores despite cereals and vegetables contributing more dietary iron. These findings
support the importance of unprocessed meat as part of a balanced diet for premenopausal women and
indicate that further research should investigate the potential for lifestyle interventions to regulate
hepcidin expression.
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